Abstracts

• Chronic lymphocytic leukemia: an enigma for both the clinician and the immunologist

  Cristina Scielzo, Michela Frenquelli, Marta Muzio, Maria T.S. Bertilaccio, Antonis Dagklis, Federico Caligaris-Cappio, Paolo Ghia

  https://doi.org/10.4081/hmr.v1i7.626

  429

  PDF: 478

  • PDF

• Moving from clinical to biological staging for the management of chronic lymphocytic leukemia

  Marco Montillo, Alessandra Tedeschi, Sara Miqueleiz, Francesca Ricci, Eleonora Vismara, Enrica Morra

  https://doi.org/10.4081/hmr.v1i7.627

  342

  PDF: 312

  • PDF

• First-line therapy of chronic lymphocytic leukemia: when and how to treat

  Ester M. Orlandi

  https://doi.org/10.4081/hmr.v1i7.628

  266

  PDF: 376

  • PDF

• The role of monoclonal antibodies in the therapeutic strategy of chronic lymphocytic leukemia

  Agostino Cortelezzi

  https://doi.org/10.4081/hmr.v1i7.629

  248

  PDF: 373

  • PDF

• Second line treatment for relapsed chronic lymphocytic leukemia

  Giuseppe Rossi

  https://doi.org/10.4081/hmr.v1i7.630

  277

  PDF: 1459

  • PDF

• Refractory chronic lymphocytic leukemia

  Giovanni Martinelli

  https://doi.org/10.4081/hmr.v1i7.631

  293

  PDF: 510

  • PDF

• Management of complications: infections, autoimmunity, cytopenias

  Fausto Rossini

  https://doi.org/10.4081/hmr.v1i7.632

  300

  PDF: 575

  • PDF